Sino Biopharmaceutical
1177.HK
#2054
Rank
NZ$13.27 B
Marketcap
$0.73
Share price
-0.30%
Change (1 day)
-8.74%
Change (1 year)
Sino Biopharmaceutical is a company based on Hong Kong that does R&D, production and sales of pharmaceuticals.

Market capitalization of Sino Biopharmaceutical (1177.HK)

Market cap: NZ$13.27 Billion

As of November 2024 Sino Biopharmaceutical has a market cap of NZ$13.27 Billion. This makes Sino Biopharmaceutical the world's 2054th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Sino Biopharmaceutical from 2004 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$13.27 B0.47%
2023NZ$13.21 B-24.47%
2022NZ$17.49 B-9.42%
2021NZ$19.31 B-24.15%
2020NZ$25.45 B-2.68%
2019NZ$26.16 B111.24%
2018NZ$12.38 B-33.08%
2017NZ$18.50 B145.63%
2016NZ$7.53 B-23.63%
2015NZ$9.86 B72.58%
2014NZ$5.71 B19.86%
2013NZ$4.76 B66.33%
2012NZ$2.86 B52.38%
2011NZ$1.88 B-21.13%
2010NZ$2.38 B18.7%
2009NZ$2.01 B279.18%
2008NZ$0.53 B-3.56%
2007NZ$0.54 B44.53%
2006NZ$0.38 B-44.01%
2005NZ$0.67 B73.11%
2004NZ$0.39 B